[HTML][HTML] Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
We present an interim analysis of a registered clinical study (NCT04800133) to establish
immunobridging with various antibody and cellular immunity markers and to compare the …
immunobridging with various antibody and cellular immunity markers and to compare the …
[HTML][HTML] Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity
…, IYS Tam, TSS Lee, JHY Lam, SM Chan… - Frontiers in …, 2022 - frontiersin.org
Our study (NCT04800133) aimed to determine the safety and immunogenicity in patients
with IEIs receiving a 3-dose primary series of mRNA vaccine BNT162b2 (age 12+) or …
with IEIs receiving a 3-dose primary series of mRNA vaccine BNT162b2 (age 12+) or …
[HTML][HTML] Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescents
…, SM Chan, S Chaothai, KKH Kwan, KCK Chan… - Frontiers in …, 2023 - frontiersin.org
Introduction Two doses of inactivated SARS-CoV-2 vaccine CoronaVac cannot elicit high
efficacy against symptomatic COVID-19, especially against the Omicron variant, but that can be …
efficacy against symptomatic COVID-19, especially against the Omicron variant, but that can be …
Antibody responses to 2 doses of mRNA COVID-19 vaccine in pediatric patients with kidney diseases
Studies in adult patients with kidney diseases have shown an attenuated immune response
to natural coronavirus disease 2019 (COVID-19) and COVID-19 vaccination. 1 The pivotal …
to natural coronavirus disease 2019 (COVID-19) and COVID-19 vaccination. 1 The pivotal …
Hesitancy, reactogenicity and immunogenicity of the mRNA and whole-virus inactivated Covid-19 vaccines in pediatric neuromuscular diseases
The mRNA-based BNT162b2 and inactivated whole-virus CoronaVac are two widely used
COVID-19 vaccines that confer immune protection to healthy individuals. However, hesitancy …
COVID-19 vaccines that confer immune protection to healthy individuals. However, hesitancy …
[HTML][HTML] Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents
…, DHL Lee, SM Chan, LCH Tsang, KCK Chan… - … and Targeted Therapy, 2022 - nature.com
The high effectiveness of the third dose of BNT162b2 in healthy adolescents against Omicron
BA.1 has been reported in some studies, but immune responses conferring this protection …
BA.1 has been reported in some studies, but immune responses conferring this protection …
[HTML][HTML] Superior antibody and membrane protein-specific T-cell responses to CoronaVac by intradermal versus intramuscular routes in adolescents
…, S Chaothai, TC Kwan, JKC Li, KCK Chan… - World Journal of …, 2024 - Springer
Background Optimising the immunogenicity of COVID-19 vaccines to improve their protection
against disease is necessary. Fractional dosing by intradermal (ID) administration has …
against disease is necessary. Fractional dosing by intradermal (ID) administration has …
Humoral and cellular immunogenicity and safety of 3 doses of CoronaVac and BNT162b2 in young children and adolescents with kidney diseases
Background Patients with kidney diseases are at risk of severe complications from COVID-19,
yet little is known about the effectiveness of COVID-19 vaccines in children and …
yet little is known about the effectiveness of COVID-19 vaccines in children and …
[HTML][HTML] Human oropharynx as natural reservoir of Streptobacillus hongkongensis
Recently, we reported the isolation of Streptobacillus hongkongensis sp. nov. from patients
with quinsy or septic arthritis. In this study, we developed a PCR sequencing test after …
with quinsy or septic arthritis. In this study, we developed a PCR sequencing test after …
Effectiveness of nurse-led disease management programs on health outcomes and health service utilization in adult patients with chronic obstructive pulmonary …
PCL Henry, CS Man, YS Fung - JBI Evidence Synthesis, 2013 - journals.lww.com
COPD is a disabling respiratory disease characterized by irreversible narrowing of small
airways, increasing airflow obstruction, loss of pulmonary elastic recoil, trapped air, and …
airways, increasing airflow obstruction, loss of pulmonary elastic recoil, trapped air, and …
